Hydrogen sulfide as a potential therapeutic target in fibrosis

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Zhang, Shufang ^a   Pan, Chuli ^a   Zhou, Feifei ^b   Yuan, Zhi ^c   Wang, Huiying ^a   Cui, Wei ^a   Zhang, Gensheng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Lihuili Hospital   (China)

^c Fenghua People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; ENZYMES; PATHOLOGY; SULFUR DETERMINATION;

ABNORMAL METABOLISM; ANTI-APOPTOSIS; ANTI-INFLAMMATION; ANTI-OXIDATION; EXPERIMENTAL ANIMALS; PATHOLOGIC CONDITIONS; SYNTHASES; THERAPEUTIC TARGETS;

HYDROGEN SULFIDE;

HYDROGEN SULFIDE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE;

ANGIOGENESIS; AUTOPHAGY; HEART MUSCLE FIBROSIS; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; LUNG FIBROSIS; NONHUMAN; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; CARDIAC MUSCLE; DRUG EFFECTS; FIBROSIS; KIDNEY; LIVER; LUNG; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ANIMALIA;

CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; FIBROSIS; HUMANS; HYDROGEN SULFIDE; KIDNEY; LIVER; LUNG; MYOCARDIUM; OXIDATIVE STRESS;

EID: 84930639366     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/593407     Document Type: Review

References (116)

1. 2S be the third endogenous gaseous transmitter?" The FASEB Journal, vol. 16, no. 13, pp. 1792-1798, 2002.
2. R. Wang, "Physiological implications of hydrogen sulfide: a whiff exploration that blossomed", Physiological Reviews, vol. 92, no. 2, pp. 791-896, 2012.
3. T. A. Wynn, "Cellular and molecular mechanisms of fibrosis", The Journal of Pathology, vol. 214, no. 2, pp. 199-210, 2008.
4. T. A. Wynn, "Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases", The Journal of Clinical Investigation, vol. 117, no. 3, pp. 524-529, 2007.
5. O. Parra, E. Monsó, M. Gallego, and J. Morera, "Inhalation of hydrogen sulphide: a case of subacute manifestations and long termsequelae", British Journal of Industrial Medicine, vol. 48, no. 4, pp. 286-287, 1991.
6. T. X. Duong, A. J. Suruda, and L. A. Maier, "Interstitial fibrosis following hydrogen sulfide exposure", American Journal of Industrial Medicine, vol. 40, no. 2, pp. 221-224, 2001.
7. L.-P. Fang, Q. Lin, C.-S. Tang, and X.-M. Liu, "Hydrogen sulfide suppresses migration, proliferation and myofibroblast transdifferentiation of human lung fibroblasts", Pulmonary Pharmacology and Therapeutics, vol. 22, no. 6, pp. 554-561, 2009.
8. L.-P. Fang, Q. Lin, C.-S. Tang, and X.-M. Liu, "Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells", Pharmacological Research, vol. 61, no. 4, pp. 298-305, 2010.
9. L. Fang, H. Li, C. Tang, B. Geng, Y. Qi, and X. Liu, "Hydrogen sulfide attenuates the pathogenesis of pulmonary fibrosis induced by bleomycin in rats", Canadian Journal of Physiology and Pharmacology, vol. 87, no. 7, pp. 531-538, 2009.
10. H. Cao, X. Zhou, J. Zhang et al., "Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance", Toxicology Letters, vol. 224, no. 3, pp. 387-394, 2014.
11. H.-N. Fan, H.-J. Wang, L. Ren, C. Wang, Y.-F. Li, and Y. Deng, "Protective effects of hydrogen sulfide on oxidativestress and fibrosis in hepatic stellate cells", Molecular Medicine Reports, vol. 7, no. 1, pp. 247-253, 2013.
12. H.-N. Fan, H.-J. Wang, L. Ren et al., "Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis", European Review for Medical and Pharmacological Sciences, vol. 17, no. 5, pp. 644-652, 2013.
13. G. Tan, S. Pan, J. Li et al., "Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats", PLoS ONE, vol. 6, no. 10, Article ID e25943, 2011.
14. K. Song, F. Wang, Q. Li et al., "Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy", Kidney International, vol. 85, no. 6, pp. 1318-1329, 2014.
15. K.-J. Jung, H.-S. Jang, J. I. Kim, S. J. Han, J.-W. Park, and K. M. Park, "Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction", Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1832, no. 12, pp. 1989-1997, 2013.
16. J. Sheng, W. Shim, H. Wei et al., "Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts", Journal of Cellular and Molecular Medicine, vol. 17, no. 10, pp. 1345-1354, 2013.
17. 2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure", American Journal of Physiology: Heart and Circulatory Physiology, vol. 298, no. 2, pp. H451-H456, 2010.
18. L.-L. Pan, X.-H. Liu, Y.-Q. Shen et al., "Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response", International Journal of Cardiology, vol. 168, no. 4, pp. 3770-3778, 2013.
19. 2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction", Zhongguo Dang Dai Er Ke Za Zhi, vol. 15, no. 10, pp. 903-908, 2013.
20. C. Wang, J. Han, L. Xiao, C.-E. Jin, D.-J. Li, and Z. Yang, "Role of hydrogen sulfide in portal hypertension and esophagogastric junction vascular disease", World Journal of Gastroenterology, vol. 20, no. 4, pp. 1079-1087, 2014.
21. E. Ruiz García-Tevijano, C. Berasain, J. A. Rodríguez et al., "Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis", Hypertension, vol. 38, no. 5, pp. 1217-1221, 2001.
22. M. P. Look, R. Riezler, C. Reichel et al., "Is the increase in serumcystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of γ-cystathionase?" Scandinavian Journal of Gastroenterology, vol. 35, no. 8, pp. 866-872, 2000.
23. S. Fiorucci, E. Distrutti, G. Cirino, and J. L. Wallace, "The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver", Gastroenterology, vol. 131, no. 1, pp. 259-271, 2006.
24. S. W. Ryter and A. M. K. Choi, "Gaseous therapeutics in acute lung injury", Comprehensive Physiology, vol. 1, no. 1, pp. 105-121, 2011.
25. J. Huang, D. Wang, J. Zheng, X. Huang, and H. Jin, "Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats", Molecular Medicine Reports, vol. 5, no. 4, pp. 923-928, 2012.
26. M. Selman, T. E. J. King, and A. Pardo, "Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy", Annals of Internal Medicine, vol. 134, no. 2, pp. 136-151, 2001.
27. J. H. Ryu, T. V. Colby, T. E. Hartman, and R. Vassallo, "Smokingrelated interstitial lung diseases: a concise review", European Respiratory Journal, vol. 17, no. 1, pp. 122-132, 2001.
28. X. Zhou, G. An, and J. Chen, "Inhibitory effects of hydrogen sulphide on pulmonary fibrosis in smoking rats via attenuation of oxidative stress and inflammation", Journal of Cellular and Molecular Medicine, vol. 18, no. 6, pp. 1098-1103, 2014.
29. K. R. Olson, N. L. Whitfield, S. E. Bearden et al., "Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism", American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 298, no. 1, pp. R51-R60, 2010.
30. 2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling", The American Journal of Physiology. Regulatory Integrative and Comparative Physiology, vol. 294, no. 6, pp. R1930-R1937, 2008.
31. D. C. Dorman, F. J.-M. Moulin, B. E. McManus, K. C. Mahle, R. A. James, and M. F. Struve, "Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium", Toxicological Sciences, vol. 65, no. 1, pp. 18-25, 2002.
32. H. Li, X.-M. Liu, B. Geng et al., "Effect of hydrogen sulfide on Bleomycin-induced pulmonary fibrosis in rats", Beijing Da Xue Xue Bao, vol. 38, no. 2, pp. 140-145, 2006.
33. R. J. Reiffenstein, W. C. Hulbert, and S. H. Roth, "Toxicology of hydrogen sulfide", Annual Review of Pharmacology and Toxicology, vol. 32, pp. 109-134, 1992.
34. R. Baskar, L. Li, and P. K. Moore, "Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells", The FASEB Journal, vol. 21, no. 1, pp. 247-255, 2007.
35. E. Mormone, J. George, and N. Nieto, "Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches", Chemico-Biological Interactions, vol. 193, no. 3, pp. 225-231, 2011.
36. Y.-P. Han, L. Zhou, J. Wang et al., "Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen", The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4820-4828, 2004.
37. S. Mani, W. Cao, L. Wu, and R. Wang, "Hydrogen sulfide and the liver", Nitric Oxide, vol. 41, pp. 62-71, 2014.
38. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis", Hepatology, vol. 42, no. 3, pp. 539-548, 2005.
39. P. Kamoun, "Endogenous production of hydrogen sulfide in mammals", Amino Acids, vol. 26, no. 3, pp. 243-254, 2004.
40. 2S production inmurine tissues", Antioxidants and Redox Signaling, vol. 15, no. 2, pp. 363-372, 2011.
41. E. Distrutti, A. Mencarelli, L. Santucci et al., "The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats", Hepatology, vol. 47, no. 2, pp. 659-667, 2008.
42. A. Bosy-Westphal, S. Petersen, H. Hinrichsen, N. Czech, and M. J. Müller, "Increased plasma homocysteine in liver cirrhosis", Hepatology Research, vol. 20, no. 1, pp. 28-38, 2001.
43. T. Taguchi, S. Awata, M. Nishioka et al., "Elevation of cystathionine γ-lyase activity in the serum of rats treated with a single dose of carbon tetrachloride", Industrial Health, vol. 33, no. 4, pp. 199-205, 1995.
44. Q. Shen, Z. Qin, and A. Lu, "Preventive effect of exogenous hydrogen sulfide on hepatic fibrosis in rats", Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 37, no. 9, pp. 911-915, 2012.
45. 2S).the third gas of interest for pharmacologists", Pharmacological Reports, vol. 59, no. 1, pp. 4-24, 2007.
46. C. Yalamanchili and M. D. Smith, "Acute hydrogen sulfide toxicity due to sewer gas exposure", The American Journal of Emergency Medicine, vol. 26, no. 4, pp. 518.e5-518.e7, 2008.
47. R. L. Chevalier, M. S. Forbes, and B. A. Thornhill, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy", Kidney International, vol. 75, no. 11, pp. 1145-1152, 2009.
48. H. W. Schnaper and J. B. Kopp, "Why kidneys fail: report from an American society of nephrology advances in research conference", Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 1777-1781, 2006.
49. M. Xia, L. Chen, R. W. Muh, P.-L. Li, and N. Li, "Productionand actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys", The Journal of Pharmacology and Experimental Therapeutics, vol. 329, no. 3, pp. 1056-1062, 2009.
50. P. Yuan, H. Xue, L. Zhou et al., "Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide", Nephrology Dialysis Transplantation, vol. 26, no. 7, pp. 2119-2126, 2011.
51. X. Zhou, Y. Feng, Z. Zhan, and J. Chen, "Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic ratmodel", The Journal of Biological Chemistry, vol. 289, no. 42, pp. 28827-28834, 2014.
52. D. Jiang, Y. Zhang, M. Yang, S. Wang, Z. Jiang, and Z. Li, "Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction", Neurourology and Urodynamics, vol. 33, no. 5, pp. 538-543, 2014.
53. A. Otunctemur, E. Ozbek, M. Dursun et al., "Protective effect of hydrogen sulfide on gentamicin-induced renal injury", Renal Failure, vol. 36, no. 6, pp. 925-931, 2014.
54. L. Yue, J. Xie, and S. Nattel, "Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation", Cardiovascular Research, vol. 89, no. 4, pp. 744-753, 2011.
55. I. Manabe, T. Shindo, and R. Nagai, "Gene expression in fibroblasts and fibrosis involvement in cardiac hypertrophy", Circulation Research, vol. 91, no. 12, pp. 1103-1113, 2002.
56. L. L. Pan, X. H. Liu, Q. H. Gong, H. B. Yang, and Y. Z. Zhu, "Role of cystathionine γ-Lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?" Antioxidants and Redox Signaling, vol. 17, no. 1, pp. 106-118, 2012.
57. M. Fu, W. Zhang, G. Yang, and R. Wang, "Is cystathionine gamma-lyase protein expressed in the heart?" Biochemical and Biophysical Research Communications, vol. 428, no. 4, pp. 469-474, 2012.
58. I. Quéré, V. Paul, C. Rouillac et al., "Spatial and temporal expression of the cystathionine β-synthase gene during early human development", Biochemical and Biophysical Research Communications, vol. 254, no. 1, pp. 127-137, 1999.
59. U. Sen, P. K. Mishra, N. Tyagi, and S. C. Tyagi, "Homocysteine to hydrogen sulfide or hypertension", Cell Biochemistry and Biophysics, vol. 57, no. 2, pp. 49-58, 2010.
60. 2S generation", Pharmacology, vol. 82, no. 3, pp. 201-213, 2008.
61. X. Wang, Q. Wang, W. Guo, and Y. Z. Zhu, "Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection", Bioscience Reports, vol. 31, no. 2, pp. 87-98, 2011.
62. N. Qipshidze, N. Metreveli, P. K. Mishra, D. Lominadze, and S. C. Tyagi, "Hydrogen sulfide mitigates cardiac remodeling duringmyocardial infarction via improvement of angiogenesis", International Journal of Biological Sciences, vol. 8, no. 4, pp. 430-441, 2012.
63. M. M. El-Seweidy, N. A. H. Sadik, and O. G. Shaker, "Role of sulfurous mineral water and sodium hydrosulfide as potent inhibitors of fibrosis in the heart of diabetic rats", Archives of Biochemistry and Biophysics, vol. 506, no. 1, pp. 48-57, 2011.
64. S. Givvimani, C. Munjal, R. Gargoum et al., "Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure", Journal of Applied Physiology, vol. 110, no. 4, pp. 1093-1100, 2011.
65. Y.-X. Shi, Y. Chen, Y.-Z. Zhu et al., "Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats", American Journal of Physiology: Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2093-H2100, 2007.
66. C. Huang, J. Kan, X. Liu et al., "Cardioprotective effects of a novel hydrogen sulfide agent-controlled release form ulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms", PLoS ONE, vol. 8, no. 7, Article ID e69205, 2013.
67. T. D. Oury, K. Thakker, M. Menache, L.-Y. Chang, J. D. Crapo, and B. J. Day, "Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin", American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 2, pp. 164-169, 2001.
68. H. Ming-Ju, H. Yih-Shou, C. Tzy-Yen, and C. Hui-Ling, "Hepatitis C virus E2 protein induce reactive oxygen species (ROS) - related fibrogenesis in the HSC-T6 hepatic stellate cell line", Journal of Cellular Biochemistry, vol. 112, no. 1, pp. 233-243, 2011.
69. J. Kim, Y. M. Seok, K.-J. Jung, and K. M. Park, "Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice", American Journal of Physiology: Renal Physiology, vol. 297, no. 2, pp. F461-F470, 2009.
70. R. Sunami, H. Sugiyama, D.-H. Wang et al., "Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction", American Journal of Physiology: Renal Physiology, vol. 286, no. 6, pp. F1030-F1038, 2004.
71. S. Kalayarasan, N. Sriram, S. Soumyakrishnan, and G. Sudhandiran, "Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2", Toxicology and Applied Pharmacology, vol. 271, no. 2, pp. 184-195, 2013.
72. M. Whiteman, J. S. Armstrong, S. H. Chu et al., "The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger"?" Journal of Neurochemistry, vol. 90, no. 3, pp. 765-768, 2004.
73. Y. Kimura and H. Kimura, "Hydrogen sulfide protects neurons from oxidative stress", The FASEB Journal, vol. 18, no. 10, pp. 1165-1167, 2004.
74. D. J. Polhemus, K. Kondo, S. Bhushan et al., "Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis", Circulation: Heart Failure, vol. 6, no. 5, pp. 1077-1086, 2013.
75. S. Kalayarasan, N. Sriram, and G. Sudhandiran, "Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta", Life Sciences, vol. 82, no. 23-24, pp. 1142-1153, 2008.
76. A. Sevanian and P. Hochstein, "Mechanisms and consequences of lipid peroxidation in biological systems", Annual Review of Nutrition, vol. 5, pp. 365-390, 1985.
77. L. Guo, H. Enzan, Y. Hayashi et al., "Increased irondeposition in rat liver fibrosis induced by a high-dose injection of dimethylnitrosamine", Experimental and Molecular Pathology, vol. 81, no. 3, pp. 255-261, 2006.
78. P. M. Snijder, R. A. De Boer, E. M. Bos et al., "Gaseous hydrogen sulfide protects againstmyocardial ischemia-reperfusion injury in mice partially independent from hypometabolism", PLoS ONE, vol. 8, no. 5, Article ID e63291, 2013.
79. D. A. Pociask, K. Chen, S. M. Choi, T. D. Oury, C. Steele, and J. K. Kolls, "γδ T cells attenuate bleomycin-induced fibrosis through the production of CXCL10", The American Journal of Pathology, vol. 178, no. 3, pp. 1167-1176, 2011.
80. K. S. Eardley and P. Cockwell, "Macrophages and progressive tubulointerstitial disease", Kidney International, vol. 68, no. 2, pp. 437-455, 2005.
81. B. Lange-Sperandio, A. Trautmann, O. Eickelberg et al., "Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice", The American Journal of Pathology, vol. 171, no. 3, pp. 861-871, 2007.
82. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, "The inflammatory response in myocardial infarction", Cardiovascular Research, vol. 53, no. 1, pp. 31-47, 2002.
83. A. S. Cowburn, J. Deighton, S. R. Walmsley, and E. R. Chilvers, "The survival effect of TNF-α in human neutrophils is mediated via NF-κB-dependent IL-8 release", European Journal of Immunology, vol. 34, no. 6, pp. 1733-1743, 2004.
84. M. Cargnello and P. P. Roux, "Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases", Microbiology and Molecular Biology Reviews, vol. 75, no. 1, pp. 50-83, 2011.
85. N. Kikuchi, Y. Ishii, Y. Morishima et al., "Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance", Respiratory Research, vol. 11, article 31, 2010.
86. F. Wang, S. Y. Liu, T. P. Du, H. Chen, Z. Y. Li, and J. W. Yan, "NF-κB inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells", Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 95-99, 2014.
87. A. S. Pachori, L. G. Melo, L. Zhang, S. D. Solomon, and V. J. Dzau, "Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery", Journal of the American College of Cardiology, vol. 47, no. 3, pp. 635-643, 2006.
88. T. A. Wynn, "Integrating mechanisms of pulmonary fibrosis", The Journal of Experimental Medicine, vol. 208, no. 7, pp. 1339-1350, 2011.
89. D. Li and S. L. Friedman, "Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy", Journal of Gastroenterology and Hepatology, vol. 14, no. 7, pp. 618-633, 1999.
90. K. E. Porter and N. A. Turner, "Cardiac fibroblasts: at the heart of myocardial remodeling", Pharmacology & Therapeutics, vol. 123, no. 2, pp. 255-278, 2009.
91. A. Masamune, T. Watanabe, K. Kikuta, and T. Shimosegawa, "Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis", Clinical Gastroenterology and Hepatology, vol. 7, no. 11, pp. S48-S54, 2009.
92. P. J. Sime and K. M. A. O'Reilly, "Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment", Clinical Immunology, vol. 99, no. 3, pp. 308-319, 2001.
93. X. Liu, H. Hu, and J. Q. Yin, "Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosis", Liver International, vol. 26, no. 1, pp. 8-22, 2006.
94. A. M. Gressner and R. Weiskirchen, "Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets", Journal of Cellular and Molecular Medicine, vol. 10, no. 1, pp. 76-99, 2006.
95. F. Y. Ma, M. Sachchithananthan, R. S. Flanc, and D. J. Nikolic-Paterson, "Mitogen activated protein kinases in renal fibrosis", Frontiers in Bioscience, vol. 1, no. 1, pp. 171-187, 2009.
96. Y. Chen and R. Wang, "The message in the air: hydrogen sulfide metabolism in chronic respiratory diseases", Respiratory Physiology & Neurobiology, vol. 184, no. 2, pp. 130-138, 2012.
97. R. K. Soon Jr. and H. F. Yee Jr., "Stellate cell contraction: role, regulation, and potential therapeutic target", Clinics in Liver Disease, vol. 12, no. 4, pp. 791-803, 2008.
98. G.-R. Li, H.-Y. Sun, J.-B. Chen, Y. Zhou, H.-F. Tse, and C.-P. Lau, "Characterization of multiple ion channels in cultured human cardiac fibroblasts", PLoS ONE, vol. 4, no. 10, Article ID e7307, 2009.
99. F. Drakopanagiotakis, A. Xifteri, V. Polychronopoulos, and D. Bouros, "Apoptosis in lung injury and fibrosis", European Respiratory Journal, vol. 32, no. 6, pp. 1631-1638, 2008.
100. J. B. Chakraborty, F. Oakley, and M. J. Walsh, "Mechanisms and biomarkers of apoptosis in liver disease and fibrosis", International Journal of Hepatology, vol. 2012, Article ID648915, 10 pages, 2012.
101. S. W. M. Van Den Borne, J. Diez, W. M. Blankesteijn, J. Verjans, L. Hofstra, and J. Narula, "Myocardial remodeling after infarction: the role ofmyofibroblasts", Nature Reviews Cardiology, vol. 7, no. 1, pp. 30-37, 2010.
102. C. Cochain, K. M. Channon, and J.-S. Silvestre, "Angiogenesis in the infarcted myocardium", Antioxidants and Redox Signaling, vol. 18, no. 9, pp. 1100-1113, 2013.
103. C. Szabó and A. Papapetropoulos, "Hydrogen sulphide and angiogenesis: mechanisms and applications", British Journal of Pharmacology, vol. 164, no. 3, pp. 853-865, 2011.
104. 2S signals through protein S-Sulfhydration", Science Signaling, vol. 2, no. 96, p. ra72, 2009.
105. G. Yang, K. Zhao, Y. Ju et al., "Hydrogen sulfide protects against cellular senescence via S-sulfhydration of keap1 and activation of Nrf2", Antioxidants & Redox Signaling, vol. 18, no. 15, pp. 1906-1919, 2013.
106. C. Guo, F. Liang, W. Shah Masood, and X. Yan, "Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent antiapoptosis and NF-κB dependent anti-inflammation pathway", European Journal of Pharmacology, vol. 725, no. 1, pp. 70-78, 2014.
107. A. S. Patel, L. Lin, A. Geyer et al., "Autophagy in idiopathic pulmonary fibrosis", PLoS ONE, vol. 7, no. 7, Article ID e41394, 2012.
108. S. Mi, Z. Li, H.-Z. Yang et al., "Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-β1-dependent and -independent mechanisms", The Journal of Immunology, vol. 187, no. 6, pp. 3003-3014, 2011.
109. A. Mallat, J. Lodder, F. Teixeira-Clerc, R. Moreau, P. Codogno, and S. Lotersztajn, "Autophagy: a multifaceted partner in liver fibrosis", Bio Med Research International, vol. 2014, Article ID 869390, 7 pages, 2014.
110. Y. Ding and M. E. Choi, "Regulation of autophagy by TGF-β: emerging role in kidney fibrosis", Seminars in Nephrology, vol. 34, no. 1, pp. 62-71, 2014.
111. D. D. Principe, P. Lista, W. Malorni, and A. M. Giammarioli, "Fibroblast autophagy in fibrotic disorders", The Journal of Pathology, vol. 229, no. 2, pp. 208-220, 2013.
112. Y. C. Wu, X. J. Wang, L. Yu et al., "Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells", PLoS ONE, vol. 7, no. 5, Article ID e37572, 2012.
113. S. Kundu, S. Pushpakumar, S. J. Khundmiri, and U. Sen, "Hydrogen sulfide mitigates hyperglycemic remodeling via liver kinase B1-adenosine monophosphate-activatedprotein kinase signaling", Biochimica et Biophysica Acta (BBA). Molecular Cell Research, vol. 1843, no. 12, pp. 2816-2826, 2014.
114. X. Zhou, G. An, and J. Chen, "Hydrogen sulfide improves left ventricular function in smoking rats via regulation of apoptosis and autophagy", Apoptosis, vol. 19, no. 6, pp. 998-1005, 2014.
115. M. Zhang, H. Shan, P. Chang et al., "Hydrogen sulfide offers neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice", PLoS ONE, vol. 9, no. 1, Article IDe87241, 2014.
116. D. Wang, Y. Ma, Z. Li et al., "The role of AKT1 and autophagy in the protective effect of hydrogen sulphide against hepaticischemia/reperfusion injury in mice", Autophagy, vol. 8, no. 6, pp. 954-962, 2012.